An institution of the Ministry of Public Health of Cuba (MINSAP)
Havana, Cuba

Centro Internacional de Restauración Neurológica

Specialized Neurological Care, Rehabilitation and Scientific Research in Cuba

Discover CIREN's neurological services, clinical evaluation programs, rehabilitation approaches, and information for international patients and their families.

About CIREN

International Center for Neurological Restoration

CIREN is a neurological medical institution in Havana, Cuba, dedicated to the assessment, treatment, rehabilitation, and scientific study of neurological disorders. Its work brings together neurology, neurosurgery, rehabilitation medicine, and allied disciplines in a multidisciplinary approach to patient care.

The institution was established to advance neurological restoration — an approach combining clinical evaluation, individualized rehabilitation, and research. CIREN has worked with patients from many countries seeking specialized neurological assessment and rehabilitation.

Medical facility exterior representing CIREN — pending authorized institutional photography

Authorized institutional photography pending. Image shown is illustrative.

1989
Founded February 26
Havana, Cuba
140,000+
Patients treated
As of 2017
94
Countries of patient origin
All continents
6
Specialized clinics
Plus REBIOGER program
Medical Services

Medical Services

Verified assessment, treatment, rehabilitation, and multidisciplinary services delivered by CIREN's clinical teams.

Neurological Evaluation

Comprehensive clinical assessment by neurology specialists.

Neurological Rehabilitation

Individualized, multidisciplinary rehabilitation programs.

Neuropsychological Assessment

Cognitive and functional evaluation of neurological conditions.

Movement and Functional Assessment

Detailed analysis of motor function and mobility.

Individualized Care Programs

Treatment plans tailored to each patient's clinical profile.

Research and Scientific Activities

Ongoing neurological research and scientific publications.

Medication Information

NeuralCIM®

NeuralCIM® is a medication associated with NeuroEPO, developed by the Center of Molecular Immunology (CIM) in Cuba. It has been studied in clinical research for neurological conditions, including a randomized clinical trial published in Alzheimer's Research & Therapy in 2023.

This section presents the medication's scientific background, published evidence, safety considerations, and the process for obtaining an individualized medical assessment. NeuralCIM® is a medication, distinct from CIREN's clinical rehabilitation services.

Neuroscience research laboratory
ATHENEA Clinical Trial
Published 2023 — Alzheimer's Research & Therapy
Mechanism
NeuroEPO-based medication

Research findings are distinct from established clinical conclusions. Never discontinue existing medication without your treating clinician's guidance.

International Patients

International Patient Services

How patients and families from other countries can contact the institution, organize their records, and request clinical review.

Patient Safety and Infection Prevention

Documented hygiene, sterilization, and clinical safety practices. Specific accreditation claims are published only with supporting evidence.

Learn more